|
[1]MADSEN MS, PETERSEN TH, SOMMER H.Segmental portal hypertension[J].Ann Surg, 1986, 204 (1) :72-77.
|
|
[2]SUN SZ, CHENG B.Diagnosis and differential diagnosis of hepatic vascular diseases[J].Chin J Diagn Pathol, 2014, 21 (6) :371-376. (in Chinese) 孙锁柱, 程波.肝血管性疾病的诊断与鉴别诊断[J].诊断病理学杂志, 2014, 21 (6) :371-376.
|
|
[3]PLESSIER A, RAUTOU PE, VALLA DC.Management of hepatic vascular diseases[J].J Hepatol, 2012, 56 (Suppl 1) :s25-s38.
|
|
[4]NAKANUMA Y, TSUNEYAMA K, OHBU M, et al.Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver[J].Pathol Res Pract, 2001, 197 (2) :65-76.
|
|
[5]PLESSIER A, DARWISH-MURAD S, HERNANDEZ-GUERRA M, et al.Acute portal vein thrombosis unrelated to cirrhosis:a prospective multicenter follow-up study[J].Hepatology, 2010, 51 (1) :210-218.
|
|
[6]TANAKA T, SUGAWARA Y, KOKUDO N.The current clinical aspects of idiopathic portal hypertension[J].Intractable Rare Dis Res, 2013, 2 (3) :94-97.
|
|
[7]RIGGIO O, GIOIA S, PENTASSUGLIO I, et al.Idiopathic noncirrhotic portal hypertension:current perspectives[J].Hepat Med, 2016, 8:81-88.
|
|
[8]RAFFA S, REVERTER JC, SEIJO S, et al.Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis[J].Clin Gastroenterol Hepatol, 2012, 10 (1) :72-78.
|
|
[9]OKUDAIRA M, OHBU M, OKUDA K.Idiopathic portal hypertension and its pathology[J].Semin Liver Dis, 2002, 22 (1) :59-72.
|
|
[10]European Association for the Study of the Liver.EASL clinical practice guidelines:vascular diseases of the liver[J].J Hepatol, 2016, 64 (1) :179-202.
|
|
[11]SARIN SK, KAPOOR D.Non-cirrhotic portal fibrosis:current concepts and management[J].J Gastroenteral Hepatol, 2002, 17 (5) :526-534.
|
|
[12]DARWISH MURAD S, PLESSIER A, HERNANDEZ-GUERRA M, et al.Etiology, management, and outcome of the Budd-Chiari syndrome[J].Ann Intern Med, 2009, 151 (3) :167-175.
|
|
[13]SMALBERG JH, ARENDS LR, VALLA DC, et al.Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis:a meta-analysis[J].Blood, 2012, 120 (25) :4921-4928.
|
|
[14]PLOMPEN EP, VALK PJ, CHU I, et al.Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis[J].Haematologica, 2015, 100 (6) :e226-e228.
|
|
[15]BAYRAKTAR Y, BALKANCI F, BAYRAKTAR M, et al.BuddChiari syndrome:a common complication of Behcet's disease[J].Am J Gastroenterol, 1997, 92 (5) :858-862.
|
|
[16]RUBBIA-BRANDT L.Sinusoidal obstruction syndrome[J].Clin Liver Dis, 2010, 14 (4) :651-668.
|
|
[17]COPPELL JA, RICHARDSON PG, SOIFFER R, et al.Hepatic veno-occlusive disease following stem cell transplantation:incidence, clinical course, and outcome[J].Biol Blood Marrow Transplant, 2010, 16 (2) :157-168.
|
|
[18]ANGLIVIEL B, BENOIST S, PENNA C, et al.Impact of chemotherapy on the accuracy of computed tomography scan for the evaluation of colorectal liver metastases[J].Ann Surg Oncol, 2009, 16 (5) :1247-1253.
|
|
[19]RICHARDSON PG, SMITH AR, TRIPLETT BM, et al.Defibrotide for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome:interim results from a treatment IND study[J].Biol Blood Marrow Transplant, 2017, 23 (6) :997-1004.
|
|
[20]BROUQUET A, BENOIST S, JULIE C, et al.Risk factors for chemotherapy-associated liver injuries:a multivariate analysis of a group of 146 patients with colorectal metastases[J].Surgery, 2009, 145 (4) :362-371.
|
|
[21]STANGE BJ, GLANEMANN M, NUESSLER NC, et al.Hepatic artery thrombosis after adult liver transplantation[J].Liver Transpl, 2003, 9 (6) :612-620.
|
DownLoad: